Start here · since 1996

Psychedelics Guide

More than 500 articles organized by substance and topic: psilocybin, LSD, ayahuasca, DMT, MDMA, mescaline and harm reduction. Rigorous information, without fear and without propaganda.

Featured articles

Explore the largest archive on psychoactive substances, published since 1996

US Psychedelic Helpline: Insights from 25,419 Interactions

A Science Advances paper details 25,419 contacts with the Fireside Project (2021-2026), primarily regarding psilocybin and trip support. Among interactions with recorded history, 2.4% mentioned schizophrenia. The data reflects only those who reached out.

Persistent difficulties after psychedelics or meditation: Emory publishes a protocol for a 1,600-person study

A team led by Emory University has posted on medRxiv the protocol for an observational study that will follow, for one year, people who attribute persistent difficulties to psychedelics or meditation. It is a research plan with no data. The sample is deliberately recruited among affected people, so it is not designed to estimate how often these problems occur.

Mind & Spirit

Inspiring reads for open minds

From our readers

Articles chosen by our community of readers

Send us your story and get featured on our homepage

2C-B in PiHKAL: Re-reading Ann Shulgin’s Account Today

We revisit Ann Shulgin’s testimony on 2C-B in PiHKAL and Sasha’s notes, providing historical context and a contemporary critical perspective.

Cannabis and Psychosis: What the Evidence Says

Can cannabis cause psychosis? We review acute effects, epidemiological data, and the limits of causality with a critical, harm-reduction lens.

What Is Ketamine: Pharmacology, Effects, and Medical Uses

What is ketamine: how it acts on the NMDA receptor, its uses in anesthesia, pain, and depression, and the risks of non-medical use.

The HIV Syringe in the Movie Theater Seat Hoax

For decades, a rumor persisted that HIV-infected syringes were being left in movie theater seats. We examine the myth, the reality, and why it mattered.

Methylphenidate and ADHD: Formulations and Diagnostic Doubts

We continue our look at methylphenidate. In our previous installment, we began discussing the drug and focused on the most well-known commercial presentation, typically prescribed to children with Attention Deficit Hyperactivity Disorder (ADHD). This product is fast-acting, with effects lasting three to six hours, requiring at least twice-daily dosing to cover the subject's active hours.

News

The latest from the psychedelic world

Latest articles

Browse our most recent articles